CBP/p300-IN-20

Overview

CBP/p300-IN-20 is a potent and selective p300/CBP inhibitor, with a pIC 50 of 10.1 for p300. CBP/p300-IN-20 can be used for the research of cancer .

Application

Products | Products > Disease Areas > Blood Disease | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Acetyltransferase | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-151812
• CAS No.: 2999742-92-4
• Molecular Formula: C22H19ClF3N5O2
• Molecular Weight: 477.87
• Purity: 98.03%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (10.46 mM); Clear solution
• Availability: In-stock

Source

Original product source